Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.

Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.

Glioblastoma is a highly aggressive tumour of the central nervous system, characterised by poor prognosis irrespective of the applied treatment. The aim of our study was to analyse whether the molecular markers of glioblastoma (i.e. TP53 and IDH1 mutations, CDKN2A deletion, EGFR amplification, chrom...

Full description

Bibliographic Details
Main Authors: Michał Bieńkowski, Sylwester Piaskowski, Ewelina Stoczyńska-Fidelus, Małgorzata Szybka, Mateusz Banaszczyk, Monika Witusik-Perkowska, Emilia Jesień-Lewandowicz, Dariusz J Jaskólski, Anna Radomiak-Załuska, Dorota Jesionek-Kupnicka, Beata Sikorska, Wielisław Papierz, Piotr Rieske, Paweł P Liberski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3675194?pdf=render

Internet

http://europepmc.org/articles/PMC3675194?pdf=render

Similar Items